| Cat. No. |
Product Name |
Information |
| PC-26640 |
MS108
ENL PROTAC
|
MS108 is a potent, selective eleven-nineteen leukemia protein (ENL) PROTAC degrader with DC50 of 0.6 nM and Dmax > 97% in MV4;11 cells. |
| PC-26588 |
TNG961
HBS1L degrader
|
TNG961 (TNG-961) is a potent, selective and oral CRBN-dependent HBS1L (GSPT3) molecular glue degrader with DC50 of 7 nM and Dmax of 98%, does not affect closely related GSPT1 protein, disrupts the HBS1L/PELO complex. |
| PC-26498 |
Cyclin D1 degrader MS28
Cyclin D1 degrader
|
Cyclin D1 degrader MS28 (XY028-133) is a potent, selective and first-in-class PROTAC degrader of cyclin D1 through recruiting the CDK4/6-cyclin D1 complex to VHL E3 ligase, effectively degrades cyclin D1 in Calu-1 cells with DC50 of 950 nM and Dmax of 90% (8 h). |
| PC-26447 |
SD-965
STAT3 PROTAC
|
SD-965 is a potent, selective, and efficacious STAT3 PROTAC degrader with DC50 of 0.14 uM and Dmax = 85%, inhibits cell growth of MOLM-16 leukemia cell line with IC50 of 1.3 nM. |
| PC-26369 |
HD-TAC7
HDAC3 PROTAC
|
HD-TAC7 is a potent, selective Cereblon-dependent HDAC3 PROTAC degrader with DC50 of 0.32 uM in RAW 264.7 cells. |
| PC-26347 |
Orevandrodeg
Ligand-directed degrader
|
Orevandrodeg (BMS-986460, CC-2043137) is a ligand-directed degrader composed of an E3 ubiquitin ligase-binding moiety that is conjugated, via a linker, to a moiety that targets a prostate specific tumor-associated antigen (TAA), with potential antineoplastic activity, androgen receptor degradation inducer. |
| PC-26133 |
GDCNF-11
GPX4 degrader
|
GDCNF-11 is a potent HSP90 interactome-mediated proteolysis targeting chimera (HIM-PROTAC) GPX4 degarder, potently induces ferroptosis via HSP90-mediated ubiquitin-proteasomal degradation of GPX4 in HT-1080 cells with DC50 of 0.08 uM. |
| PC-26132 |
dGPX4
GPX4 PROTAC
|
dGPX4 is a potent GPX4 PROTAC degrader, depletes GPX4 via proteasomal protein degradation, induces cell-selective ferroptosis by targeting cancer cell microenvironment. |
| PC-26131 |
GDAz-3
GPX4 degrader
|
GDAz-3 is a potent GPX4-targeting HSP70-PROTAC, potently and rapidly eliminates GPX4 in HT1080 cells (DC50=0.13 uM), thereby triggering ferroptosis with high selectivity. |
| PC-26015 |
CCT400028
Aurora A PROTAC
|
CCT400028 is a second-generation alisertib-derived Aurora A PROTAC with DC50 of 29 nM in MV4-11 leukemia cells, D max=85%, shows excellent selectivity in proteomic and kinase selectivity profiling. |
| PC-25972 |
WWZ-11-098
CDK6 degrader
|
WWZ-11-098 is a potent, selective Palbociclib-based CDK6 degrader with DC50 of 2.6 nM and Dmax of 99.9 % in MOLT4 cells via CRBN-dependent manner, while sparing CDK1, CDK2, CDK4, and CDK9. |
| PC-25906 |
G6374
IRE1 PROTAC
|
G6374 is a selective, effective PROTAC degrader for endogenous IRE1 with DC50 of 0.04 uM and Dmax of 93% in AMO1 multiple myeloma (MM) cells. |
